The FDA and the Federal Trade Commission have posted joint warning letters to companies that make and distribute opioid cessation products.
The two watchdogs warned that the companies are illegally marketing their unapproved products as treatments or even cures for people with opioid addiction and withdrawal. Selling unapproved products as therapies for opioid addiction is a violation of the Federal Food, Drug and Cosmetic Act and also violates the Federal Trade Commission Act, according to the FDA and FTC.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA, FTC warn companies over deceptive opioid cessation products appeared first on MassDevice.